Is there a role for soy isoflavones in the therapeutic approach to polycystic ovary syndrome? Results from a pilot study

Fertility and Sterility

Volumn 90, Issue 5, 2008, Pages 1826-1833

  Romualdi, Daniela ^a   Costantini, Barbara ^a   Campagna, Giuseppe ^a   Lanzone, Antonio ^a,b   Guido, Maurizio ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b OASI RESEARCH INSTITUTE IRCCS   (Italy)

Author keywords

Genistein; insulin; obesity; PCOS; soy isoflavones

Indexed keywords

CARBOHYDRATE; CHOLESTEROL; FITOGEN; GENISTEIN; HIGH DENSITY LIPOPROTEIN; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOCOMPONENT INSULIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; DRUG EFFECT; DYSLIPIDEMIA; ECHOGRAPHY; ENDOCRINE DISEASE; FEMALE; HORMONE DETERMINATION; HORMONE METABOLISM; HOSPITALIZATION; HUMAN; HYPERINSULINEMIA; INSULIN METABOLISM; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; MENSTRUAL CYCLE; METABOLIC DISORDER; OBESITY; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; BLOOD GLUCOSE; BODY MASS INDEX; CHOLESTEROL; DYSLIPIDEMIAS; FEMALE; GENISTEIN; HORMONES; HUMANS; HYPERINSULINISM; INSULIN; LIPID METABOLISM; OBESITY; PHYTOESTROGENS; PILOT PROJECTS; POLYCYSTIC OVARY SYNDROME; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; TRIGLYCERIDES; WAIST-HIP RATIO; YOUNG ADULT;

EID: 55249091152     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2007.09.020     Document Type: Article

References (47)

1. Barber T.M., McCarthy M.I., Wass J.A., and Franks S. Obesity and polycystic ovary syndrome. Clin Endocrinol (Oxf) 65 (2006) 137-145
2. Apridonidze T., Essah P.A., Iuorno M.J., and Nestler J.E. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 90 (2005) 1929-1935
3. Bhathena S.J., and Velasquez M.T. Beneficial role of dietary phytoestrogens in obesity and diabetes. Am J Clin Nutr 76 (2002) 1191-1201
4. Setchell K.D. Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. Am J Clin Nutr 68 (1998) 1333S-1346S
5. Adlercreutz H., Hockerstedt K., Bannwart C., Bloigu S., Hamalainen E., Fotsis T., et al. Effect of dietary components, including lignans and phytoestrogens, on enterohepatic circulation and liver metabolism of estrogens and on sex hormone binding globulin (SHBG). J Steroid Biochem 27 (1987) 1135-1144
6. Cassidy A., Bingham S., and Setchell K.D. Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am J Clin Nutr 60 (1994) 333-340
7. Lu L.J., Anderson K.E., Grady J.J., and Nagamani M. Effects of soya consumption for one month on steroid hormones in premenopausal women: implications for breast cancer risk reduction. Cancer Epidemiol Biomarkers Prev 5 (1996) 63-70
8. Sirtori C.R., Agradi E., Conti F., Mantero O., and Gatti E. Soybean-protein diet in the treatment of type-II hyperlipoproteinaemia. Lancet 1 (1977) 275-277
9. Descovich G.C., Ceredi C., Gaddi A., Benassi M.S., Mannino G., Colombo L., et al. Multicentre study of soybean protein diet for outpatient hyper-cholesterolaemic patients. Lancet 4 (1980) 709-712
10. Anthony M.S., Clarkson T.B., Hughes Jr. C.L., Morgan T.M., and Burke G.L. Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkeys. J Nutr 126 (1996) 43-50
11. Nogowski L., Mackowiak P., Kandulska K., Szkudelski T., and Nowak K.W. Genistein-induced changes in lipid metabolism of ovariectomized rats. Ann Nutr Metab 42 (1998) 360-366
12. Jayagopal V., Albertazzi P., Kilpatrick E.S., Howarth E.M., Jennings P.E., Hepburn D.A., et al. Beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes. Diabetes Care 25 (2002) 1709-1714
13. Fedorak R.N., Cheeseman C.I., Thomson A.B., and Porter V.M. Altered glucose carrier expression: mechanism of intestinal adaptation during streptozocin-induced diabetes in rats. Am J Physiol 261 (1991) G585-G591
14. Persaud S.J., Harris T.E., Burns C.J., and Jones P.M. Tyrosine kinases play a permissive role in glucose-induced insulin secretion from adult rat islets. J Mol Endocrinol 22 (1999) 19-28
15. The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19 (2004) 41-47
16. Belosi C., Selvaggi L., Apa R., Guido M., Romualdi D., Fulghesu A.M., et al. Is the PCOS diagnosis solved by ESHRE/ASRM 2003 consensus or could it include ultrasound examination of the ovarian stroma?. Hum Reprod 21 (2006) 3108-3115
17. Fulghesu A.M., Ciampelli M., Belosi C., Apa R., Pavone V., and Lanzone A. A new ultrasound criterion for the diagnosis of polycystic ovary syndrome: the ovarian stroma/total area ratio. Fertil Steril 76 (2001) 326-331
18. New M.I., Lorenzen F., Lerner A.J., Kohn B., Oberfield S.E., Pollack M.S., et al. Genotyping steroid 21-hydroxilase deficiency: hormonal reference data. J Clin Endocrinol Metab 57 (1983) 320-326
19. Ciampelli M., Fulghesu A.M., Cucinelli F., Pavone V., Ronsisvalle E., Guido M., et al. Impact of insulin and body mass index on metabolic and endocrine variables in polycystic ovary syndrome. Metabolism 48 (1999) 167-172
20. De Fronzo J.P., Tobin J.D., and Andrei R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237 (1979) E214-E223
21. Bergman R.N., Finegood D.T., and Ader M. Assessment of insulin sensitivity in vivo. Endocr Rev 6 (1985) 45-86
22. Faber O.K., Christensen K., Kehelet H., Madsbad S., and Binder C. Decreased insulin removal contributes to hyperinsulinemia in obesity. J Clin Endocrinol Metab 53 (1981) 618-621
23. Loon A.T. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 23 (2000) S4-S19
24. Cucinelli F., Paparella P.L., Soranna L., Barini A., Cinque B., Mancuso S., et al. Differential effect of transdermal estrogen plus progestagen replacement therapy on insulin metabolism in postmenopausal women: relation to their insulinemic secretion. Eur J Endocrinol 140 (1999) 1215-1223
25. Lanzone A., Fulghesu A.M., Fortini A., Cutillo G., Cucinelli F., Di Simone M., et al. Effect of opiate receptor blockade on the insulin response to oral glucose load in polycystic ovarian disease. Hum Reprod 6 (1991) 1043-1049
26. Van Hooff M.H., Voorhorst F.J., Kaptein M.B., Hirasing R.A., Koppenaal C., and Schoemaker J. Endocrine features of polycystic ovary syndrome in a random population sample of 14-16 year old adolescents. Hum Reprod 14 (1999) 2223-2229
27. Murkies A.L., Wilcox G., and Davis S.R. Clinical review 92: phytoestrogens. J Clin Endocrinol Metab 83 (1998) 297-303
28. Erdman Jr. J.W., Badger T.M., Lampe J.W., Setchell K.D., and Messina M. Not all soy products are created equal: caution needed in interpretation of research results. J Nutr 134 (2004) 229S-1233S
29. Kuiper G.G.J.M., Lemmen J.G., and Carlsson B. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor ß. Endocrinology 139 (1998) 4252-4263
30. Duncan A.M., Merz B.E., Xu X., Nagel T.C., Phipps W.R., and Kurzer M.S. Soy isoflavones exert modest hormonal effects in premenopausal women. J Clin Endocrinol Metab 84 (1999) 192-197
31. Yoo R.Y., Dewan A., Basu R., Newfield R., Gottschalk M., and Chang R.J. Increased luteinizing hormone pulse frequency in obese oligomenorrheic girls with no evidence of hyperandrogenism. Fertil Steril 85 (2006) 1049-1056
32. Wu A.H., Stanczyk F.Z., Hendrich S., Murphy P.A., Zhang C., Wan P., et al. Effects of soy foods on ovarian function in premenopausal women. Br J Cancer 82 (2000) 1879-1886
33. Lu L.J., Anderson K.E., Grady J.J., Kohen F., and Nagamani M. Decreased ovarian hormones during a soya diet: implications for breast cancer prevention. Cancer Res 60 (2000) 4112-4121
34. Cassidy A., Bingham S., and Setchell K. Biological effects of isoflavones in young women: importance of the chemical composition of soybean products. Br J Nutr 74 (1995) 587-601
35. Kellis Jr. J.T., and Vickery L.E. Inhibition of human estrogen synthetase (aromatase) by flavones. Science 225 (1984) 1032-1034
36. Mousavi Y., and Adlercreutz H. Genistein is an effective stimulator of sex hormone-binding globulin production in hepatocarcinoma human liver cancer cells and suppresses proliferation of these cells in culture. Steroids 58 (1993) 301-304
37. Pino A.M., Valladares L.E., Palma M.A., Mancilla A.M., Yanez M., and Albala C. Dietary isoflavones affect sex hormone-binding globulin levels in postmenopausal women. J Clin Endocrinol Metab 85 (2000) 2797-2800
38. Vedavanam K., Srijayanta S., O'Reilly J., Raman A., and Wiseman H. Antioxidant action and potential antidiabetic properties of an isoflavonoid-containing soyabean phytochemical extract (SPE). Phytother Res 13 (1996) 601-608
39. Wagner J.D., Cefalu W.T., Anthony M.S., Litwak K.N., Zhang L., and Clarkson T.B. Dietary soy protein and estrogen replacement therapy improve cardiovascular risk factors and decrease aortic cholesteryl ester content in ovariectomized cynomolgus monkeys. Metabolism 46 (1997) 698-705
40. Blakesmith S.J., Lyons-Wall P.M., George C., Joannou G.E., Petocz P., and Samman S. Effects of supplementation with purified red clover (Trifolium pratense) isoflavones on plasma lipids and insulin resistance in healthy premenopausal women. Br J Nutr 89 (2003) 467-474
41. Hall W.L., Vafeiadou K., Hallund J., Bugel S., Reimann M., Koebnick C., et al. Soy-isoflavone-enriched foods and markers of lipid and glucose metabolism in postmenopausal women: interactions with genotype and equol production. Am J Clin Nutr 83 (2006) 592-600
42. Hermansen K., Sondergaard M., Hoie L., Carstensen M., and Brock B. Beneficial effects of a soy-based dietary supplement on lipid levels and cardiovascular risk markers in type 2 diabetic subjects. Diabetes Care 24 (2001) 228-233
43. Merz-Demlow B.E., Duncan A.M., Wangen K.E., Xu X., Carr T.P., Phipps W.R., et al. Soy isoflavones improve plasma lipids in normocholesterolemic, premenopausal women. Am J Clin Nutr 71 (2000) 1462-1469
44. Torres N., Torre-Villalvazo I., and Tovar A.R. Regulation of lipid metabolism by soy protein and its implication in diseases mediated by lipid disorders. J Nutr Biochem 17 (2006) 365-373
45. Sclavo M. Cardiovascular risk factors and prevention in women: similarities and differences. Ital Heart J 2 Suppl 2 (2001) 125-141
46. Castelli W.P. The new pathophysiology of coronary artery disease. Am J Cardiol 82 (1998) 60t-65t
47. Abler A., Smith J.A., Randazzo P.A., Rothenberg P.L., and Jarett L. Genistein differentially inhibits postreceptor effects of insulin in rat adipocytes without inhibiting the insulin receptor kinase. J Biol Chem 267 (1992) 3946-3951